United Therapeutics authorizes additional $2 billion share repurchase
United Therapeutics Corporation announced an additional $2 billion share repurchase authorization.
Story updates
11:04:57 AM UTC
SquawkNews
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the company’s Board of Directors has authorized a new share repurchase program for up to $2 billion of the company’s common stock, available through October 21, 2027.“We have the balance sheet and fre…
11:10:20 AM UTC
SquawkNews
United Therapeutics authorized a share repurchase program of up to $2 billion, available through October 21, 2027.Key Highlights:Original SEC Filing: UNITED THERAPEUTICS Corp [ UTHR ] - 8-K - Oct. 22, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important infor…